PN HESI Pharmacology Exam Prep Document | 2026/2027
Edition | 200 Verified Questions - 190 Questions with Answers
PN HESI Pharmacology Exam 2026-190 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100% Verified
Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive review guide is meticulously designed for nursing students preparing for the PN
HESI Pharmacology exam. It contains 200 verified questions with correct answers and detailed
rationales, reflecting the most current pharmacological principles and nursing practices. The content is
organized to reinforce critical drug knowledge, safety, and patient education, ensuring a thorough
understanding of pharmacology as applied in practical nursing. Updated for the 2026/2027 academic
year, this resource is an essential tool for achieving a high score and demonstrating clinical
competence.
Key Features:
Pharmacokinetics and pharmacodynamics
Drug classifications and mechanisms of action
Nursing interventions and patient education
Adverse effects, contraindications, and drug interactions
Dosage calculations and medication administration
Legal and ethical considerations in pharmacology
Updates for 2026:
- Incorporate the latest FDA drug approvals and safety alerts
- Align with the 2026-2027 HESI PN test blueprint
- Expand rationales to include evidence-based practice guidelines
- Enhance questions on high-alert medications and look-alike/sound-alike drugs
- Integrate clinical judgment models for critical thinking
Abstract:
This exam preparation document offers a rigorous and systematic review of pharmacology for practical nursing
students. It comprises 200 multiple-choice questions that mirror the format and difficulty of the PN HESI
Pharmacology exam. Each question is accompanied by a correct answer and a detailed rationale that explains the
underlying pharmacological concept, nursing implications, and clinical reasoning. The content spans essential
topics such as drug classifications, mechanisms of action, therapeutic uses, adverse effects, and nursing
considerations across various body systems. Special emphasis is placed on safe medication administration, patient
education, and the prevention of medication errors. Updated to reflect the 2026-2027 academic year, this resource
integrates current guidelines and best practices, ensuring that students are well-prepared to excel on their exam
and in clinical practice. The rationales are designed to promote deep understanding and retention, making this an
invaluable tool for both initial learning and final review.
Keywords:
PN HESI Pharmacology, Exam review, 200 questions, Detailed rationales, Nursing pharmacology, Drug safety,
2026-2027 edition
Answer Format:
Each question is presented in a multiple-choice format with four options. The correct answer is clearly indicated,
followed by a comprehensive rationale that explains why it is correct and why the other options are incorrect.
Rationales include pharmacological principles, nursing interventions, and clinical pearls to enhance understanding.
Compliance Checklist:
Page 1
, Aligned with the latest HESI PN Pharmacology test plan
Includes 200 verified questions with correct answers
Provides detailed rationales for all answers
Updated with 2026-2027 guidelines and drug information
Suitable for self-assessment and exam preparation
Covers all major pharmacology content areas
Content Area Overview:
Content Area Questions Key Topics Weight
Pharmacokinetics and 1-30 Absorption, distribution, metabolism, 15%
Pharmacodynamics excretion; receptor interactions;
dose-response relationships
Autonomic Nervous System 31-60 Cholinergic, anticholinergic, adrenergic, 15%
Drugs antiadrenergic agents
Cardiovascular and Renal Drugs 61-90 Antihypertensives, antiarrhythmics, 15%
diuretics, anticoagulants
Central Nervous System Drugs 91-120 Analgesics, sedatives, antidepressants, 15%
antipsychotics
Endocrine and Metabolic Drugs 121-150 Insulin, oral hypoglycemics, thyroid 15%
hormones, corticosteroids
Anti-Infective and 151-180 Antibiotics, antivirals, antifungals, 15%
Chemotherapeutic Agents antineoplastics
Miscellaneous and Special 181-200 Herbal supplements, pediatric and geriatric 10%
Populations considerations, pregnancy and lactation
Page 2
,Q1. A patient with heart failure is prescribed digoxin and furosemide. Which
laboratory value most increases the risk of digoxin toxicity?
A. Serum potassium 3.0 mEq/L
B. Serum sodium 135 mEq/L
C. Serum creatinine 1.2 mg/dL
D. Serum magnesium 2.0 mEq/L
Correct Answer: A. Serum potassium 3.0 mEq/L
Rationale: Hypokalemia (K+ <3.5) sensitizes the myocardium to digoxin, increasing
toxicity risk. Furosemide causes potassium loss. Low sodium, normal creatinine, and
normal magnesium do not directly enhance digoxin toxicity.
Why Wrong:
B - Hyponatremia is not a primary risk factor for digoxin toxicity.
C - Elevated creatinine may indicate renal impairment, but 1.2 mg/dL is near normal
and not the key risk.
D - Normal magnesium does not increase digoxin toxicity risk; hypomagnesemia
would.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 35.
Q2. A patient on warfarin has an INR of 5.2 and is bleeding. Which intervention is
most appropriate?
A. Administer vitamin K 10 mg IV
B. Administer protamine sulfate 50 mg IV
C. Administer fresh frozen plasma (FFP) only
D. Hold warfarin and repeat INR in 24 hours
Correct Answer: A. Administer vitamin K 10 mg IV
Rationale: Warfarin overdose with bleeding and INR >5 requires vitamin K to reverse
anticoagulation. FFP is used for severe bleeding but vitamin K is the specific antidote.
Protamine reverses heparin, not warfarin. Holding warfarin alone is insufficient.
Why Wrong:
B - Protamine sulfate is the antidote for heparin, not warfarin.
C - FFP provides clotting factors but does not address the ongoing warfarin effect;
vitamin K is required.
D - Holding warfarin is too slow for active bleeding; immediate reversal is needed.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 36.
Q3. Which drug is most likely to cause a 'disulfiram-like' reaction when combined
with alcohol?
A. Metronidazole
B. Ciprofloxacin
Page 3
, C. Amoxicillin
D. Doxycycline
Correct Answer: A. Metronidazole
Rationale: Metronidazole inhibits acetaldehyde dehydrogenase, causing acetaldehyde
accumulation when alcohol is consumed, leading to flushing, nausea, and tachycardia.
Ciprofloxacin, amoxicillin, and doxycycline do not cause this reaction.
Why Wrong:
B - Ciprofloxacin may cause CNS effects but not a disulfiram-like reaction.
C - Amoxicillin has no clinically significant interaction with alcohol.
D - Doxycycline does not cause a disulfiram-like reaction.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 79.
Q4. A patient is receiving an IV infusion of dopamine at 5 mcg/kg/min. Which
assessment finding indicates a therapeutic response?
A. Increased urine output
B. Decreased heart rate
C. Decreased blood pressure
D. Increased respiratory rate
Correct Answer: A. Increased urine output
Rationale: At low doses (1-5 mcg/kg/min), dopamine stimulates dopaminergic receptors in
the kidney, increasing renal blood flow and urine output. Higher doses affect beta and
alpha receptors. Bradycardia, hypotension, and tachypnea are not expected therapeutic
responses.
Why Wrong:
B - Dopamine typically increases heart rate at higher doses, not decreases.
C - Dopamine increases blood pressure, not decreases, at beta/alpha doses.
D - Respiratory rate is not a direct indicator of dopamine's therapeutic effect.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 18.
Q5. Which medication requires the nurse to monitor for 'red man syndrome' during
IV administration?
A. Vancomycin
B. Ceftriaxone
C. Azithromycin
D. Gentamicin
Correct Answer: A. Vancomycin
Rationale: Vancomycin infusion can cause histamine release, leading to flushing,
erythema, and pruritus (red man syndrome). It is prevented by slow infusion and
Page 4
Edition | 200 Verified Questions - 190 Questions with Answers
PN HESI Pharmacology Exam 2026-190 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100% Verified
Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive review guide is meticulously designed for nursing students preparing for the PN
HESI Pharmacology exam. It contains 200 verified questions with correct answers and detailed
rationales, reflecting the most current pharmacological principles and nursing practices. The content is
organized to reinforce critical drug knowledge, safety, and patient education, ensuring a thorough
understanding of pharmacology as applied in practical nursing. Updated for the 2026/2027 academic
year, this resource is an essential tool for achieving a high score and demonstrating clinical
competence.
Key Features:
Pharmacokinetics and pharmacodynamics
Drug classifications and mechanisms of action
Nursing interventions and patient education
Adverse effects, contraindications, and drug interactions
Dosage calculations and medication administration
Legal and ethical considerations in pharmacology
Updates for 2026:
- Incorporate the latest FDA drug approvals and safety alerts
- Align with the 2026-2027 HESI PN test blueprint
- Expand rationales to include evidence-based practice guidelines
- Enhance questions on high-alert medications and look-alike/sound-alike drugs
- Integrate clinical judgment models for critical thinking
Abstract:
This exam preparation document offers a rigorous and systematic review of pharmacology for practical nursing
students. It comprises 200 multiple-choice questions that mirror the format and difficulty of the PN HESI
Pharmacology exam. Each question is accompanied by a correct answer and a detailed rationale that explains the
underlying pharmacological concept, nursing implications, and clinical reasoning. The content spans essential
topics such as drug classifications, mechanisms of action, therapeutic uses, adverse effects, and nursing
considerations across various body systems. Special emphasis is placed on safe medication administration, patient
education, and the prevention of medication errors. Updated to reflect the 2026-2027 academic year, this resource
integrates current guidelines and best practices, ensuring that students are well-prepared to excel on their exam
and in clinical practice. The rationales are designed to promote deep understanding and retention, making this an
invaluable tool for both initial learning and final review.
Keywords:
PN HESI Pharmacology, Exam review, 200 questions, Detailed rationales, Nursing pharmacology, Drug safety,
2026-2027 edition
Answer Format:
Each question is presented in a multiple-choice format with four options. The correct answer is clearly indicated,
followed by a comprehensive rationale that explains why it is correct and why the other options are incorrect.
Rationales include pharmacological principles, nursing interventions, and clinical pearls to enhance understanding.
Compliance Checklist:
Page 1
, Aligned with the latest HESI PN Pharmacology test plan
Includes 200 verified questions with correct answers
Provides detailed rationales for all answers
Updated with 2026-2027 guidelines and drug information
Suitable for self-assessment and exam preparation
Covers all major pharmacology content areas
Content Area Overview:
Content Area Questions Key Topics Weight
Pharmacokinetics and 1-30 Absorption, distribution, metabolism, 15%
Pharmacodynamics excretion; receptor interactions;
dose-response relationships
Autonomic Nervous System 31-60 Cholinergic, anticholinergic, adrenergic, 15%
Drugs antiadrenergic agents
Cardiovascular and Renal Drugs 61-90 Antihypertensives, antiarrhythmics, 15%
diuretics, anticoagulants
Central Nervous System Drugs 91-120 Analgesics, sedatives, antidepressants, 15%
antipsychotics
Endocrine and Metabolic Drugs 121-150 Insulin, oral hypoglycemics, thyroid 15%
hormones, corticosteroids
Anti-Infective and 151-180 Antibiotics, antivirals, antifungals, 15%
Chemotherapeutic Agents antineoplastics
Miscellaneous and Special 181-200 Herbal supplements, pediatric and geriatric 10%
Populations considerations, pregnancy and lactation
Page 2
,Q1. A patient with heart failure is prescribed digoxin and furosemide. Which
laboratory value most increases the risk of digoxin toxicity?
A. Serum potassium 3.0 mEq/L
B. Serum sodium 135 mEq/L
C. Serum creatinine 1.2 mg/dL
D. Serum magnesium 2.0 mEq/L
Correct Answer: A. Serum potassium 3.0 mEq/L
Rationale: Hypokalemia (K+ <3.5) sensitizes the myocardium to digoxin, increasing
toxicity risk. Furosemide causes potassium loss. Low sodium, normal creatinine, and
normal magnesium do not directly enhance digoxin toxicity.
Why Wrong:
B - Hyponatremia is not a primary risk factor for digoxin toxicity.
C - Elevated creatinine may indicate renal impairment, but 1.2 mg/dL is near normal
and not the key risk.
D - Normal magnesium does not increase digoxin toxicity risk; hypomagnesemia
would.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 35.
Q2. A patient on warfarin has an INR of 5.2 and is bleeding. Which intervention is
most appropriate?
A. Administer vitamin K 10 mg IV
B. Administer protamine sulfate 50 mg IV
C. Administer fresh frozen plasma (FFP) only
D. Hold warfarin and repeat INR in 24 hours
Correct Answer: A. Administer vitamin K 10 mg IV
Rationale: Warfarin overdose with bleeding and INR >5 requires vitamin K to reverse
anticoagulation. FFP is used for severe bleeding but vitamin K is the specific antidote.
Protamine reverses heparin, not warfarin. Holding warfarin alone is insufficient.
Why Wrong:
B - Protamine sulfate is the antidote for heparin, not warfarin.
C - FFP provides clotting factors but does not address the ongoing warfarin effect;
vitamin K is required.
D - Holding warfarin is too slow for active bleeding; immediate reversal is needed.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 36.
Q3. Which drug is most likely to cause a 'disulfiram-like' reaction when combined
with alcohol?
A. Metronidazole
B. Ciprofloxacin
Page 3
, C. Amoxicillin
D. Doxycycline
Correct Answer: A. Metronidazole
Rationale: Metronidazole inhibits acetaldehyde dehydrogenase, causing acetaldehyde
accumulation when alcohol is consumed, leading to flushing, nausea, and tachycardia.
Ciprofloxacin, amoxicillin, and doxycycline do not cause this reaction.
Why Wrong:
B - Ciprofloxacin may cause CNS effects but not a disulfiram-like reaction.
C - Amoxicillin has no clinically significant interaction with alcohol.
D - Doxycycline does not cause a disulfiram-like reaction.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 79.
Q4. A patient is receiving an IV infusion of dopamine at 5 mcg/kg/min. Which
assessment finding indicates a therapeutic response?
A. Increased urine output
B. Decreased heart rate
C. Decreased blood pressure
D. Increased respiratory rate
Correct Answer: A. Increased urine output
Rationale: At low doses (1-5 mcg/kg/min), dopamine stimulates dopaminergic receptors in
the kidney, increasing renal blood flow and urine output. Higher doses affect beta and
alpha receptors. Bradycardia, hypotension, and tachypnea are not expected therapeutic
responses.
Why Wrong:
B - Dopamine typically increases heart rate at higher doses, not decreases.
C - Dopamine increases blood pressure, not decreases, at beta/alpha doses.
D - Respiratory rate is not a direct indicator of dopamine's therapeutic effect.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 18.
Q5. Which medication requires the nurse to monitor for 'red man syndrome' during
IV administration?
A. Vancomycin
B. Ceftriaxone
C. Azithromycin
D. Gentamicin
Correct Answer: A. Vancomycin
Rationale: Vancomycin infusion can cause histamine release, leading to flushing,
erythema, and pruritus (red man syndrome). It is prevented by slow infusion and
Page 4
